Diagnostic Testing For STD’s Market By Type (Syphilis Testing, Gonorrhea Testing, Chlamydia Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Others), By Location (Laboratory Testing, Point Of Care Testing) - Growth, Future Prospects & Competitive Analysis, 2021 – 2029
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Diagnostic Testing For STD’s Market
2.2. Global Diagnostic Testing For STD’s Market, By Type, 2023 (US$ Million)
2.3. Global Diagnostic Testing For STD’s Market, By Location, 2023 (US$ Million)
2.4. Global Diagnostic Testing For STD’s Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Diagnostic Testing For STD’s Market: Competitive Analysis
3.1. Market Positioning of Key Diagnostic Testing For STD’s Market Vendors
3.2. Strategies Adopted by Diagnostic Testing For STD’s Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Diagnostic Testing For STD’s Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Diagnostic Testing For STD’s Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
6. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Laboratory Testing
6.3.2. Point of Care Testing
7. North America Diagnostic Testing For STD’s Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
7.3. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
7.4.Diagnostic Testing For STD’s Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
7.4.1.1.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
7.4.1.2.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
7.4.1.3.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8. UK and European Union Diagnostic Testing For STD’s Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.3. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8.4.Diagnostic Testing For STD’s Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.4.1.1.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.4.1.2.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.4.1.3.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.4.1.4.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.4.1.5.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
8.4.1.6.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9. Asia Pacific Diagnostic Testing For STD’s Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.3. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9.4.Diagnostic Testing For STD’s Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.4.1.1.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.4.1.2.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.4.1.3.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.4.1.4.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.4.1.5.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
9.4.1.6.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
10. Latin America Diagnostic Testing For STD’s Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
10.3. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
10.4.Diagnostic Testing For STD’s Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
10.4.1.1.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
10.4.1.2.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
10.4.1.3.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
11. Middle East and Africa Diagnostic Testing For STD’s Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
11.3. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
11.4.Diagnostic Testing For STD’s Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
11.4.1.1.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
11.4.1.2.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Diagnostic Testing For STD’s Market: By Type, 2022-2032, USD (Million)
11.4.1.3.2. Diagnostic Testing For STD’s Market: By Location, 2022-2032, USD (Million)
12. Company Profile
12.1. Abbott Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Bio-Rad Laboratories, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. bioMeriuex
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Danaher Corporation
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Diasorin S.p.A
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. F. Hoffmann La-Roche Ltd.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Hologic, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. MedMira, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Qaigen, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Siemens Healthcare AG
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives